Synthesis, characterization and bio-evaluation of novel series of pyrazoline derivatives as potential antifungal agents
Abstract
In this study, a series of novel α, β-unsaturated carbonyl compounds (3a-j) and their pyrazoline derivatives (4a-e and 5a-b) were designed and successfully synthesized. All synthesized compounds were characterized using various spectroscopic techniques, including 1H NMR, 13C NMR, and mass spectrometry. The biological activity of these compounds was evaluated against five bacterial strains (Pseudomonas aeruginosa, Klebsiella pneumoniae, Escherichia coli, Staphylococcus aureus, and Acinetobacter baumannii) and three fungal strains (Candida tropicalis, Candida parapsilosis, and Candida albicans). The results revealed that compound (4c) exhibited potent antifungal activity with a minimum inhibitory concentration (MIC) of 6.25 µg/mL across all tested strains and zone of inhibition (ZOI) against Candida albicans is 27 mm. Furthermore, time kill kinetics of Candida albicans and haemolysis assays also perform in support of their antifungal activity. Additionally, all synthesized compounds were subjected to computational analysis using molecular descriptors, ADMET, molecular docking, and molecular dynamics to find protein-ligand interactions. Molecular docking studies indicated that the most effective antifungal compounds (3h and 4c) exhibited binding energies of -8.76 and -8.44 kcal/mol for DHFR and -7.96 and -8.24 kcal/mol for NMT1, respectively. The obtained results revealed that these compounds exhibit potential interactions with antifungal targets as dual inhibitors. As a…
How strong is the evidence?
Evidence Hub reads this as a experimental / empirical study, done in computer models (in silico), not in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.